Seegene Inc
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection … Read more
Seegene Inc (096530) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.037x
Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.037x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.18 Billion) by net assets (₩1.00 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Seegene Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Seegene Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shen Ma Industry Co Ltd
SHG:600810
|
0.029x |
|
Rogers Sugar Inc
PINK:RSGUF
|
0.006x |
|
Bright Minds Biosciences Inc
NASDAQ:DRUG
|
-0.065x |
|
Enaex S.A
SN:ENAEX
|
0.106x |
|
Guangdong Haomei New Material Co Lt
SHE:002988
|
0.017x |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
0.052x |
|
Drägerwerk AG & Co. KGaA
PINK:DGWPF
|
0.050x |
|
Hanwang Technology Co Ltd
SHE:002362
|
-0.036x |
Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩981.48 Billion | ₩85.39 Billion | 0.087x | -5.57% |
| 2023-12-31 | ₩1.03 Trillion | ₩94.93 Billion | 0.092x | -66.85% |
| 2022-12-31 | ₩1.15 Trillion | ₩319.01 Billion | 0.278x | -10.02% |
| 2021-12-31 | ₩1.08 Trillion | ₩334.02 Billion | 0.309x | -47.98% |
| 2020-12-31 | ₩645.32 Billion | ₩383.16 Billion | 0.594x | +233.73% |
| 2019-12-31 | ₩152.55 Billion | ₩27.14 Billion | 0.178x | +62.59% |
| 2018-12-31 | ₩128.03 Billion | ₩14.01 Billion | 0.109x | +35.27% |
| 2017-12-31 | ₩125.04 Billion | ₩10.12 Billion | 0.081x | -30.63% |
| 2016-12-31 | ₩141.97 Billion | ₩16.56 Billion | 0.117x | +612.54% |
| 2015-12-31 | ₩135.09 Billion | ₩-3.07 Billion | -0.023x | -131.84% |
| 2014-12-31 | ₩94.83 Billion | ₩6.78 Billion | 0.071x | +308.60% |
| 2013-12-31 | ₩84.44 Billion | ₩-2.89 Billion | -0.034x | -139.12% |
| 2012-12-31 | ₩41.94 Billion | ₩3.67 Billion | 0.088x | -- |